NAFDAC approves the use of the Johnson and Johnson COVID-19 vaccine in Nigeria

The National Agency for Food and Drug Administration and Control has approved the use of the Johnson and Johnson COVID-19 vaccine in Nigeria.

In a statement signed by the agency’s spokesperson, Dr Abubakar Jimoh,the agency’s Director-General, Prof Moji Adeyeye, explained that After a thorough evaluation, the NAFDAC vaccine committee concluded that the data on the vaccine were robust and met criteria for efficacy, safety, and quality

According to her, data has also shown that the benefits of the vaccine outweigh its potential risk hence the need for approval.

The NAFDAC Boss added that results from a clinical trial involving people in the United States, South Africa, and Latin America countries have shown that Janssen Covid-19 vaccine was very useful in preventing Covid-19 in people from 18 years of age.

Unlike the AstraZeneca Vaccine which is administered in two doses, the Janssen vaccine is administered in a single dose.

Leave a Reply

Your email address will not be published. Required fields are marked *